Jaiswal S, Libby P. Clonal haematopoiesis: Connecting ageing and inflammation in cardiovascular disease [published online ahead of print Aug 12, 2019]. Nat Rev Cardiol doi:10.1038/s41569-019-0247-5.
Libby P, et al.. Clonal hematopoiesis: Crossroads of aging, cardiovascular disease, and cancer: JACC review topic of the week. J Am Coll Cardiol 2019; 74:567–577.
Martincorena I, Campbell PJ. Somatic mutation in cancer and normal cells. Science 2015; 349:1483–1489.
Xie M, et al.. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med 2014; 20:1472–8.
Steensma DP, et al.. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood 2015; 126:9–16.
Jaiswal S, et al.. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 2014; 371:2488–2498.
Jaiswal S, et al.. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med 2017; 377:111–121.
Dorsheimer L, et al.. Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure. JAMA Cardiol 2019; 4:25–33.
Mas-Peiro S, et al.. Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation [published online ahead of print Sep 2019]. Eur Heart J doi:10.1093/eurheartj/ehz591.
Sano S, et al.. CRISPR-mediated gene editing to assess the roles of TET2 and DNMT3A in clonal hematopoiesis and cardiovascular disease. Circ Res 2018; 123:335–341.
Sano S, et al.. JAK2 (V617F)-mediated clonal hematopoiesis accelerates pathological remodeling in murine heart failure. JACC Basic Transl Sci 2019; 4:684–697.
Wada J, Makino H. Innate immunity in diabetes and diabetic nephropathy. Nat Rev Nephrol 2016; 12:13–26.
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory